Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase II regimen-finding study

Phoebe Rich, B. Sigurgeirsson, D. Thaci, J. P. Ortonne, C. Paul, R. E. Schopf, A. Morita, K. Roseau, E. Harfst, A. Guettner, M. MacHacek, C. Papavassilis

Research output: Contribution to journalArticlepeer-review

214 Scopus citations

Fingerprint

Dive into the research topics of 'Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase II regimen-finding study'. Together they form a unique fingerprint.

Medicine & Life Sciences